Skip to main content

EMBLEM™ S-ICD System

Subcutaneous Implantable Defibrillator

Progressive Therapy Starts with S-ICD

The EMBLEM MRI S-ICD system is the first and only subcutaneous implantable defibrillator that provides protection for a broad range of patients at risk for sudden cardiac death while also providing protection from the risks and complications associated with transvenous leads. And it remains outside the sternum, never touching the heart.

  • Works for patients of all ages
  • Minimizes serious complications
  • Offers a less invasive alternative that’s predictable, safer and simpler
  • Is more flexible and easier to extract 
130,000+
 

Fewer Risks - TODAY

Both acute and chronic TV-ICD complications are more prevalent than generally acknowledged. Many patients are getting devices earlier in life and with better management of heart failure are living longer and are more likely to outlive their transvenous lead. EMBLEM MRI S-ICD gives these patients a less-invasive solution that avoids the risks that come with TV-ICD.
3-4% of patients with TV-ICD suffer lead malfunctions in the first year of implant2
About 25% mechanical failure rate for TV-ICD at 10 years2
4% infection rate for TV-ICD at 10 years2
 

Training & Education

Explore continuing education courses, best practices modules and other training and resources for S-ICD.

Visit EDUCARE


Implant Procedure

Implant Procedure

Learn about advancements in the S-ICD implant procedure, including the 2-incision and intermuscular implant techniques.

Button
Clinical Data

Clinical Data

Explore clinical outcomes and learn about the first prospective, randomized, non-inferiority clinical trial comparing S-ICD to TV-ICD

Button

Videos & Resources

Hear physician perspectives about S-ICD, find media information, and download product images, patient videos and more.

Button
 
References
1. Boston Scientific CRM Product Performance Report, Q4 2023.
2. Koneru, JN, Jones, PW, Hammill, EF, Wold, N, and Ellenbogen, KA, Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads. J Am Heart Assoc, 2018. 7(10).
Top